Evaluating glycemic control algorithms by computer simulations.

Abstract Background: Numerous guidelines and algorithms exist to achieve glycemic control. Their strengths and weaknesses are difficult to assess without head-to-head comparison in time-consuming clinical trials. We hypothesized that computer simulations may be useful. Methods: Two open-label random...

Descripción completa

Detalles Bibliográficos
Publicado en:Diabetes Technology & Therapeutics Vol. 13; no. 7; pp. 713 - 723
Autores principales: Wilinska ME, Blaha J, Chassin LJ, Cordingley JJ, Dormand NC, Ellmerer M, Haluzik M, Plank J, Vlasselaers D, Wouters PJ, Hovorka R
Formato: research Journal Article
Publicado: Mary Ann Liebert, Inc. 2011 Jul
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108233401&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 108233401
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15209156
        N3C
      jtl: Diabetes Technology & Therapeutics
      issn: 15209156
      maglogo: N
    pubinfo:
      dt: 2011 Jul
      vid: 13
      iid: 7
      pid: 1365
      pub: Mary Ann Liebert, Inc.
      place: New Rochelle, New York
    artinfo:
      ui:
        108233401
        108233401
        2011187252
        10.1089/dia.2011.0016
        NLM21488803
        108233401
      ppf: 713
      ppct: 10
      formats:
      tig:
        atl: Evaluating glycemic control algorithms by computer simulations.
      aug:
        au:
          Wilinska ME
          Blaha J
          Chassin LJ
          Cordingley JJ
          Dormand NC
          Ellmerer M
          Haluzik M
          Plank J
          Vlasselaers D
          Wouters PJ
          Hovorka R
        affil: Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom
      sug:
        subj:
          Algorithms
          Computer Simulation
          Critical Illness Therapy
          Diabetes Mellitus Complications
          Diabetes Mellitus Drug Therapy
          Hyperglycemia Prevention and Control
          Hypoglycemia Prevention and Control
          Adult
          Aged
          Aged, 80 and Over
          Blood Glucose Analysis
          Clinical Trials
          Diabetes Mellitus Diet Therapy
          Female
          Human
          Hypoglycemic Agents Administration and Dosage
          Hypoglycemic Agents Adverse Effects
          Hypoglycemic Agents Therapeutic Use
          Insulin Administration and Dosage
          Insulin Adverse Effects
          Insulin Therapeutic Use
          Intensive Care Units
          Male
          Middle Age
          Research, Medical Methods
          Retrospective Design
          Risk Assessment Methods
          Adult: 19-44 years
          Aged: 65+ years
          Aged, 80 & over
          Middle Aged: 45-64 years
          Female
          Male
      ab: Abstract Background: Numerous guidelines and algorithms exist to achieve glycemic control. Their strengths and weaknesses are difficult to assess without head-to-head comparison in time-consuming clinical trials. We hypothesized that computer simulations may be useful. Methods: Two open-label randomized clinical trials were replicated using computer simulations. One study compared performance of the enhanced model predictive control (eMPC) algorithm at two intensive care units in the United Kingdom and Belgium. The other study compared three glucose control algorithms-eMPC, Matias (the absolute glucose protocol), and Bath (the relative glucose change protocol)-in a single intensive care unit. Computer simulations utilized a virtual population of 56 critically ill subjects derived from routine data collected at four European surgical and medical intensive care units. Results: In agreement with the first clinical study, computer simulations reproduced the main finding and discriminated between the two intensive care units in terms of the sampling interval (1.3 h vs. 1.8 h, United Kingdom vs. Belgium; P < 0.01). Other glucose control metrics were comparable between simulations and clinical results. The principal outcome of the second study was also reproduced. The eMPC demonstrated better performance compared with the Matias and Bath algorithms as assessed by the time when plasma glucose was in the target range between 4.4 and 6.1 mmol/L (65% vs. 43% vs. 42% [P < 0.001], eMPC vs. Matias vs. Bath) without increasing the risk of severe hypoglycemia. Conclusions: Computer simulations may provide resource-efficient means for preclinical evaluation of algorithms for glycemic control in the critically ill.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N